Laveder F, Marcolongo R
Institute of Clinical Medicine, University of Padua, Italy.
Immunol Cell Biol. 1996 Apr;74(2):159-62. doi: 10.1038/icb.1996.21.
The cause of bone marrow failure in aplastic anaemia (AA) is still unknown; however, it is clear that acquired AA is a heterogeneous disease including basically different pathophysiological conditions. Causative agents, clinically associated with AA, possibly exert their action through restricted pathways. Some theoretical and experimental data show that programmed cell death (PCD) or apoptosis is physiologically important in normal haematopoiesis and could be involved in the pathophysiological events responsible for the development of AA. Therefore, it is intriguing to hypothesize that the pathogenetic mechanism underlying most cases of acquired AA could be represented by an excessive and/or uncontrolled triggering of PCD in haematopoietic stem cells. Investigations to test this hypothesis are proposed.
再生障碍性贫血(AA)中骨髓衰竭的病因仍不清楚;然而,很明显获得性AA是一种异质性疾病,包括基本不同的病理生理状况。与AA临床相关的致病因素可能通过有限的途径发挥作用。一些理论和实验数据表明,程序性细胞死亡(PCD)或凋亡在正常造血过程中具有重要的生理意义,并且可能参与了导致AA发生的病理生理事件。因此,有趣的是推测大多数获得性AA病例的发病机制可能表现为造血干细胞中PCD的过度和/或不受控制的触发。本文提出了检验这一假设的研究。